col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Contemporary Clinical Trials
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―16 The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial Bryan Bunning, Haley Hedlin, Natasha Purington, Vandana Sundaram, Kristopher Kapphahn, Yingjie Weng, et al. (+11)
2 [GO] 2021―Jul―02 An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic K. Shin Park, Jennifer L. Etnier
3 [GO] 2021―May―29 The link between vitamin D and COVID-19 Daniel M.O. Campos, Edilson D. Silva Jr, Umberto L. Fulco, Jonas I.N. Oliveira
4 [GO] 2021―May―29 Response to the letter to the editor: “The link between Vitamin D and COVID-19 Davaasambuu Ganmaa, Rui Wang, Walter C. Willett, JoAnn E. Manson
5 [GO] 2021―Apr―20 Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic Seol Ju E. Moon, Annette DeVito Dabbs, Andrea L. Hergendroeder, Melissa L. Vendetti, Kristen B. Jones, Bryan M. Willey, et al. (+2)
6 [GO] 2021―Mar―26 Risk-based centralized data monitoring of clinical trials at the time of COVID-19 pandemic Most Alina Afroz, Grant Schwarber, Mohammad Alfrad Nobel Bhuiyan
7 [GO] 2021―Mar―12 A multi-center trial of exercise and testosterone therapy in women after hip fracture: Design, methods and impact of the COVID-19 pandemic Ellen F. Binder, Jesse C. Christensen, Jennifer Stevens-Lapsley, Jenna Bartley, Sarah D. Berry, Adrian S. Dobs, et al. (+12)
8 [GO] 2021―Feb―23 RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19 Veeral Ajmera, Wesley K. Thompson, Davey M. Smith, Atul Malhotra, Ravindra L. Mehta, Vaishal Tolia, et al. (+6)
9 [GO] 2021―Jan―27 Clinical trial preparations for the next pandemic Jay Herson
10 [GO] 2021―Jan―10 Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials Ahmad Al-Abdouh, Anas Bizanti, Mahmoud Barbarawi, Ahmad Jabri, Ashish Kumar, Oluwaseun E. Fashanu, et al. (+4)
11 [GO] 2020―Dec―18 Guest Editors'-in-Chief Note to COVID-19 Special Issue. Zheng Su, Sue-Jane Wang
12 [GO] 2020―Dec―04 Reporting and design of randomized controlled trials for COVID-19: A systematic review Alison Dillman, Jay J.H. Park, Michael J. Zoratti, Noor-E Zannat, Zelyn Lee, Louis Dron, et al. (+6)
13 [GO] 2020―Nov―11 Causal inference methods for small non-randomized studies: Methods and an application in COVID-19 Sarah Friedrich, Tim Friede
14 [GO] 2020―Nov―10 Reacting to crises: The COVID-19 impact on biostatistics/epidemiology Robert T. O'Neill
15 [GO] 2020―Nov―02 Modifications to communities for healthy Living trial design resulting from COVID-19 Kirsten K. Davison, Sebastien Hanuese
16 [GO] 2020―Oct―23 Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country Geert Molenberghs, Marc Buyse, Steven Abrams, Niel Hens, Philippe Beutels, Christel Faes, et al. (+13)
17 [GO] 2020―Oct―10 The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design Rui Wang, Victor DeGruttola, Quanhong Lei, Kenneth H. Mayer, Susan Redline, Aditi Hazra, et al. (+4)
18 [GO] 2020―Oct―06 TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol Maria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, et al. (+15)
19 [GO] 2020―Sep―20 Data monitoring committees for clinical trials evaluating treatments of COVID-19 Tobias Mütze, Tim Friede
20 [GO] 2020―Sep―20 COVID-19 hits a trial: Arguments against hastily deviating from the plan Anika Großhennig, Armin Koch
21 [GO] 2020―Sep―15 Semiparametric Bayesian inference for the transmission dynamics of COVID-19 with a state-space model Tianjian Zhou, Yuan Ji
22 [GO] 2020―Sep―12 Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19 Zachary R. McCaw, Lu Tian, Kevin N. Sheth, Wan-Ting Hsu, W. Taylor Kimberly, Lee-Jen Wei
23 [GO] 2020―Aug―08 Covid-19 pandemic research opportunity: Is the Middle East & North Africa (MENA) missing out? Halah Ibrahim, Ashraf M. Kamour, Thana Harhara, Waqar H. Gaba, Satish C. Nair
24 [GO] 2020―Aug―06 The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan Hsiao-Hui Tsou, Yu-Chieh Cheng, Hsiang-Yu Yuan, Ya-Ting Hsu, Hsiao-Yu Wu, Fang-Jing Lee, et al. (+7)
25 [GO] 2020―Apr―06 Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research? Hala T. Borno, Eric J. Small


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.010 sec